Abstract
Some of the main therapeutic targets previously selected for the design of drug candidates in inflammatory diseases will be investigated with the use of different methodologies of Computational Medicinal Chemistry. The candidate has experience and he will work with ligand- and structure-based drug design (of the targets here investigated). (AU)